SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CHDX--US China Industrial Exchange

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Barry Shore who wrote (20)4/25/1998 10:08:00 AM
From: WWS  Read Replies (1) of 77
 
Barry, very interesting news yesterday (after the close) from PLC systems. Their transmyocardial revascularization (TMR) laser was recommended (unanimously) for FDA approval by their FDA advisory panel. biz.yahoo.com
While this is just short of full FDA approval, it is a very positive development for them. Note that their stock price dropped off precipitously in the days leading up to the panel meeting, probably because many feared that PLC systems would fail for the second time to convince the advisory panel with their supportive data. But surprise, success was the order of the day. While I'm afraid that playing PLC systems stock on monday will be about as easy as trying to jump aboard a moving train, at least CHDX stockholders can take consolation from the fact that we have distribution rights to the TMR laser for all of China. Best Regards, Bill.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext